Literature DB >> 1368937

Vaccinia and other poxvirus expression vectors.

B Moss1.   

Abstract

Over the past year improvements have been made in recombinant vaccinia virus gene expression and a new method for inserting DNA into the poxvirus genome has been developed, along with alternative methods for selecting recombinant viruses. Attenuated and non-replicating vaccinia virus and avian poxvirus vectors are now being used successfully. Field trials of an oral, wild-life rabies vaccine and phase 1 testing of human vaccines derived from vaccinia virus are underway.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1368937     DOI： 10.1016/0958-1669(92)90080-3

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN： 0958-1669            Impact factor:   9.740


  5 in total

Review 1.  Overview of vector design for mammalian gene expression.

Authors:  R J Kaufman
Journal:  Mol Biotechnol       Date:  2000-10       Impact factor: 2.695

2.  Role of cell signaling in poxvirus-mediated foreign gene expression in mammalian cells.

Authors:  Ningjie Hu; Richard Yu; Cecilia Shikuma; Bruce Shiramizu; Mario A Ostrwoski; Qigui Yu
Journal:  Vaccine       Date:  2009-03-10       Impact factor: 3.641

3.  Highly attenuated poxviruses induce functional priming of neutrophils in vitro.

Authors:  R Förster; G Wolf; A Mayr
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

Review 4.  Avipoxviruses: infection biology and their use as vaccine vectors.

Authors:  Simon C Weli; Morten Tryland
Journal:  Virol J       Date:  2011-02-03       Impact factor: 4.099

5.  Six host-range restricted poxviruses from three genera induce distinct gene expression profiles in an in vivo mouse model.

Authors:  Kristy Offerman; Armin Deffur; Olivia Carulei; Robert Wilkinson; Nicola Douglass; Anna-Lise Williamson
Journal:  BMC Genomics       Date:  2015-07-08       Impact factor: 3.969
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.